Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Psychedelics Today – Tales of Transformation

Terran Biosciences discovers what may be the first new salts, co-crystals,...

FILAMENT HEALTH ANNOUNCES FIRST EVER NAGOYA PROTOCOL-COMPLIANT SHIPMENT OF IBOGA FROM...

Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The...

PT410 – Manufacturing MDMA and Why Creating MDMA Analogs Is So...

FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Psychedelics Weekly – Multi-Stakeholder Capitalism, Psilocybin Service Centers Begin Opening in...

Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol...

GH Research Reports First Quarter 2023 Financial Results and Provides Business...

1...666768...218 Page 67 of 218

EDITOR PICKS

Pα+ Psychedelic Bulletin #221: Helus Reports Murky Phase 2a Results; AtaiBeckley...

Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects...

Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin